Identification of potential targets for ovarian cancer treatment by systematic bioinformatics analysis

被引:1
|
作者
Ye, Q. [1 ]
Lei, L. [1 ]
Aili, A. X. [1 ]
机构
[1] Tongji Univ, Shanghai East Hosp, Dept Obstet & Gynecol, Shanghai 200120, Peoples R China
关键词
Ovarian cancer; Protein-protein interaction; Co-expression network; Gene ontology analysis; Pathway enrichment analysis; GENE-EXPRESSION; TRANSCRIPTION FACTORS; P53; MICRORNAS; ASPM; OVEREXPRESSION; RESISTANCE; ONCOGENE; NETWORKS; DATABASE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of investigation: To provide a systematic overview to understand the mechanism of ovarian cancer. Materials and Methods: Data of GSE14407 downloaded from Gene Expression Omnibus (GEO) database and differentially expressed genes (DEGs) were identified. Gene ontology and pathway enrichment analysis were performed by Database for Annotation, Visualization and Integrated Discovery (DAVID). Furthermore, the authors constructed the protein-protein interaction (PPI) network and co-expression networks by Cytoscape. Results: A total 1,442 genes were identified to be differentially expressed. Regulatory effects of DEGs mainly focused on cell cycle, transcription regulation, and cellular protein metabolic process. Significant pathways were determined to be p53 signaling pathway, amino sugar, and nucleotide sugar metabolism. The most significant transcription factor was aryl hydrocarbon receptor nuclear translocator (ARNT). Abnormal spindle-like microcephaly-associated protein (ASPM), Aurora kinase (AURKA), Cyclin-A2 (CCNA2), G2/mitotic-specific cyclin-B1, (CCNB1), and Cyclin-dependent kinase 1 (CDK1) were significant nodes in PPI network. Conclusion: The significant genes and pathways show potential targets for the treatment of ovarian cancer.
引用
收藏
页码:283 / 289
页数:7
相关论文
共 50 条
  • [21] Identification of potential immunotherapy biomarkers for breast cancer by bioinformatics analysis
    Song, Yao
    Lu, Meiling
    Feng, Lijin
    Chen, Qian
    Huang, Hua
    Lin, Qing
    BIOSCIENCE REPORTS, 2022, 42 (02)
  • [22] Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis
    Zhang, Xue
    Wei, Xuan
    Bai, Gaigai
    Huang, Xueyao
    Hu, Shunxue
    Mao, Hongluan
    Liu, Peishu
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 8629 - 8646
  • [23] Bioinformatics analysis and verification of molecular targets in ovarian cancer stem-like cells
    Behera, Abhijeet
    Ashraf, Rahail
    Srivastava, Amit Kumar
    Kumar, Sanjay
    HELIYON, 2020, 6 (09)
  • [24] Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis
    Zhao, Xin
    Ren, Yiming
    Cui, Naiqiang
    Wang, Ximo
    Cui, Yunfeng
    MEDICINE, 2018, 97 (39)
  • [25] Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments
    Lingling Gao
    Xiao Li
    Qian Guo
    Xin Nie
    Yingying Hao
    Qing Liu
    Juanjuan Liu
    Liancheng Zhu
    Limei Yan
    Bei Lin
    Cancer Cell International, 20
  • [26] Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments
    Gao, Lingling
    Li, Xiao
    Guo, Qian
    Nie, Xin
    Hao, Yingying
    Liu, Qing
    Liu, Juanjuan
    Zhu, Liancheng
    Yan, Limei
    Lin, Bei
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [27] Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis
    Zhanzhan Xu
    Yu Zhou
    Yexuan Cao
    Thi Lan Anh Dinh
    Jing Wan
    Min Zhao
    Medical Oncology, 2016, 33
  • [28] Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis
    Xu, Zhanzhan
    Zhou, Yu
    Cao, Yexuan
    Thi Lan Anh Dinh
    Wan, Jing
    Zhao, Min
    MEDICAL ONCOLOGY, 2016, 33 (11)
  • [29] Bioinformatics analysis of potential therapeutic targets among ARHGAP genes in breast cancer
    Chen, Wei-Xian
    Lou, Ming
    Cheng, Lin
    Qian, Qi
    Xu, Ling-Yun
    Sun, Li
    Zhu, Yu-Lan
    Dai, Hong
    ONCOLOGY LETTERS, 2019, 18 (06) : 6017 - 6025
  • [30] Identification of biomarkers and potential drug targets in osteoarthritis based on bioinformatics analysis and mendelian randomization
    Cheng, Feng
    Li, Mengying
    Hua, Haotian
    Zhang, Ruikun
    Zhu, Yiwen
    Zhu, Yingjia
    Zhang, Yang
    Tong, Peijian
    FRONTIERS IN PHARMACOLOGY, 2024, 15